Literature DB >> 15165652

Polyanalgesic Consensus Conference 2003: an update on the management of pain by intraspinal drug delivery-- report of an expert panel.

Samuel J Hassenbusch1, Russell K Portenoy, Michael Cousins, Eric Buchser, Timothy R Deer, Stuart L Du Pen, James Eisenach, Kenneth A Follett, Keith R Hildebrand, Elliot S Krames, Robert M Levy, Pamela P Palmer, James P Rathmell, Richard L Rauck, Peter S Staats, Lisa Stearns, K Dean Willis.   

Abstract

Intraspinal drug infusion using fully implantable pump and catheter systems is a safe and effective therapy for selected patients with chronic pain. The options for this approach are increasing, as drugs that are commercially available for systemic administration are adapted to this use and other drugs that are in development specifically for intraspinal administration become available. In 2000 a Polyanalgesic Consensus Conference was organized to evaluate the existing literature and develop guidelines for drug selection. The major outcome of this effort, an algorithm for drug selection, was based on the best available evidence at the time. Rapid changes have occurred in the science and practice of intraspinal infusion and a Polyanalgesic Consensus Conference 2003 was organized to pursue the following goals: 1) to review the literature on intraspinal drug infusion since 1999, 2) to revise the 2000 drug-selection algorithm, 3) to develop guidelines for optimizing drug dosage and concentration, 4) to create a process for documenting minimum evidence supporting the use of a drug for intraspinal infusion, and 5) to clarify issues pertaining to compounding of drugs. Based on the best available evidence and expert opinion, consensus recommendations were developed in all these areas. The panel's conclusions may provide a foundation for clinical practice and a rational basis for new research.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15165652     DOI: 10.1016/j.jpainsymman.2004.03.001

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN: 0885-3924            Impact factor:   3.612


  22 in total

Review 1.  Intrathecal Analgesia for Chronic Refractory Pain: Current and Future Prospects.

Authors:  Catherine Smyth; Nadera Ahmadzai; Jason Wentzell; Ashley Pardoe; Andrew Tse; Tiffany Nguyen; Yvette Goddard; Shona Nair; Patricia A Poulin; Becky Skidmore; Mohammed T Ansari
Journal:  Drugs       Date:  2015-11       Impact factor: 9.546

Review 2.  Implantable intrathecal pumps for chronic pain: highlights and updates.

Authors:  Karen H Knight; Frances M Brand; Ali S Mchaourab; Giorgio Veneziano
Journal:  Croat Med J       Date:  2007-02       Impact factor: 1.351

3.  Intrathecal medications in post-herpetic neuralgia.

Authors:  Andrew J Fabiano; Carolyn Doyle; Robert J Plunkett
Journal:  Pain Med       Date:  2012-05-23       Impact factor: 3.750

Review 4.  Intrathecal drug delivery for chronic pain management-scope, limitations and future.

Authors:  M Czernicki; G Sinovich; I Mihaylov; B Nejad; S Kunnumpurath; G Kodumudi; N Vadivelu
Journal:  J Clin Monit Comput       Date:  2014-08-31       Impact factor: 2.502

Review 5.  [Importance of intrathecal pain therapy].

Authors:  R Likar; W Ilias; H Kloimstein; A Kofler; H G Kress; J Neuhold; M M Pinter; M C Spendel
Journal:  Schmerz       Date:  2007-02       Impact factor: 1.107

Review 6.  Current developments in intraspinal agents for cancer and noncancer pain.

Authors:  Erin F Lawson; Mark S Wallace
Journal:  Curr Pain Headache Rep       Date:  2010-02

7.  The neurological safety of epidural pamidronate in rats.

Authors:  Pyung Bok Lee; Yong Chul Kim; Chul Joong Lee; Hye Young Shin; Seung Yun Lee; Jong Cook Park; Yun Suk Choi; Chong Soo Kim; Sang Hyun Park
Journal:  Korean J Pain       Date:  2010-05-31

Review 8.  Intraspinal techniques for pain management in cancer patients: a systematic review.

Authors:  Jeff Myers; Vincent Chan; Virginia Jarvis; Cindy Walker-Dilks
Journal:  Support Care Cancer       Date:  2010-02       Impact factor: 3.603

Review 9.  Intrathecal pumps.

Authors:  Shawn Belverud; Alon Mogilner; Michael Schulder
Journal:  Neurotherapeutics       Date:  2008-01       Impact factor: 7.620

10.  Safety and efficacy of intrathecal ziconotide in the management of severe chronic pain.

Authors:  Howard S Smith; Timothy R Deer
Journal:  Ther Clin Risk Manag       Date:  2009-07-12       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.